UAE pharmaceutical regulation operates on a registration model: before any medicine can be legally distributed commercially, it must be registered with the Ministry of Health and Prevention (MoHAP), which evaluates safety, efficacy, and manufacturing quality data submitted by the applicant before granting approval.
This registration requirement applies broadly across pharmaceutical categories, and HGH formulations (branded somatropin products) are registered and regulated exactly like other prescription medicines under this same framework, rather than receiving any special treatment as a hormone product.
Once registered, prescription-only medicines like HGH can be legally dispensed exclusively by licensed pharmacies against a valid prescription issued by a UAE-registered physician. This dispensing control is separate from the registration step and adds another layer of oversight specific to how the product reaches a patient.
This two-part structure — registration for market entry, prescription control for dispensing — is standard for pharmaceuticals across most developed regulatory systems and is not unique to HGH, though HGH sits firmly within it as a hormone therapy with real physiological effects and documented risks.
Unscheduled research peptides — the category REVIVE LAB UAE's actual catalog occupies — are not formulated, marketed, or labeled as medicines for human therapeutic use, and have not gone through this drug-approval and registration pathway. This is a meaningful legal distinction rather than a marketing distinction.
Because they are not classified as pharmaceutical drugs, these products are sold for laboratory and research use under a different regulatory framework entirely, distinct from both the registration requirements and the prescription-dispensing controls that apply to HGH.
Understanding this framework clarifies why REVIVE LAB UAE's catalog and an approved pharmaceutical like HGH occupy entirely separate regulatory categories, and why REVIVE LAB UAE cannot and does not sell HGH regardless of demand or interest from researchers.
This is general regulatory background information, not legal advice, and specific classification determinations for any product rest with MoHAP. REVIVE LAB UAE does not sell HGH and does not offer legal interpretation of pharmaceutical regulation.